| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-00 |
| filingDate |
2003-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e5da7dd73f832bf6d2053641be200d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a6fb01b42757520ffedc6a38a98d877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8f87d526c3e7eeb0a5f09f64e48df5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46124204fd06f27ee6998a08db655f36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02cc616ab35696a3b3f7f6d796b81a30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9a11472fe5b9f55696fcb83cc6df259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16dba15dad1d48d8bdd9ccb0740fa18d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f324c9a1e83bd721a2e6dfa104c95848 |
| publicationDate |
2004-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2512389-A1 |
| titleOfInvention |
Methods of producing c-aryl glucoside sglt2 inhibitors |
| abstract |
Method for the production of C-aryl glucoside SGLT2 inhibitors useful for the treatment of diabetes and related diseases. and intermediates thereof. The C-aryl glucosides may be complexed with amino acid complex forming reagents. |
| priorityDate |
2003-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |